Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 4
2017 2
2018 1
2019 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Scalable detection of technically challenging variants through modified next-generation sequencing.
Rojahn S, Hambuch T, Adrian J, Gafni E, Gileta A, Hatchell H, Johnson B, Kallman B, Karfilis K, Kautzer C, Kennemer M, Kirk L, Kvitek D, Lettes J, Macrae F, Mendez F, Paul J, Pellegrino M, Preciado R, Risinger J, Schultz M, Spurka L, Swamy S, Truty R, Usem N, Velenich A, Aradhya S. Rojahn S, et al. Among authors: spurka l. Mol Genet Genomic Med. 2022 Dec;10(12):e2072. doi: 10.1002/mgg3.2072. Epub 2022 Oct 17. Mol Genet Genomic Med. 2022. PMID: 36251442 Free PMC article.
Sequencing as a first-line methodology for cystic fibrosis carrier screening.
Beauchamp KA, Johansen Taber KA, Grauman PV, Spurka L, Lim-Harashima J, Svenson A, Goldberg JD, Muzzey D. Beauchamp KA, et al. Among authors: spurka l. Genet Med. 2019 Nov;21(11):2569-2576. doi: 10.1038/s41436-019-0525-y. Epub 2019 Apr 30. Genet Med. 2019. PMID: 31036917 Free PMC article.
Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment.
Vysotskaia VS, Hogan GJ, Gould GM, Wang X, Robertson AD, Haas KR, Theilmann MR, Spurka L, Grauman PV, Lai HH, Jeon D, Haliburton G, Leggett M, Chu CS, Iori K, Maguire JR, Ready K, Evans EA, Kang HP, Haque IS. Vysotskaia VS, et al. Among authors: spurka l. PeerJ. 2017 Feb 23;5:e3046. doi: 10.7717/peerj.3046. eCollection 2017. PeerJ. 2017. PMID: 28243543 Free PMC article.
Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS.
Taylor-Harding B, Aspuria PJ, Agadjanian H, Cheon DJ, Mizuno T, Greenberg D, Allen JR, Spurka L, Funari V, Spiteri E, Wang Q, Orsulic S, Walsh C, Karlan BY, Wiedemeyer WR. Taylor-Harding B, et al. Among authors: spurka l. Oncotarget. 2015 Jan 20;6(2):696-714. doi: 10.18632/oncotarget.2673. Oncotarget. 2015. PMID: 25557169 Free PMC article.
11 results